Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004959220 | SCV005453050 | uncertain significance | Inborn genetic diseases | 2024-12-07 | criteria provided, single submitter | clinical testing | The c.1102G>C (p.G368R) alteration is located in exon 11 (coding exon 10) of the ANXA11 gene. This alteration results from a G to C substitution at nucleotide position 1102, causing the glycine (G) at amino acid position 368 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |